|
1 Company |
|
4 Products |
|
4 Products |
|
4 Mechanisms of Action |
|
0 Trials |
|
46 News |
|
- | metformin / Generic mfg.
Enrollment change, Trial termination: Metformin and Congenital Nephrogenic Diabetes Insipidus (clinicaltrials.gov) - Jul 17, 2018
P1, N=2, Terminated, Sponsor: Emory University
N=20 --> 2 | Active, not recruiting --> Terminated; Lack of effect in initial subjects
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Tracking Neurodegeneration in Early Wolfram Syndrome (clinicaltrials.gov) - Jul 11, 2018
P=N/A, N=101, Completed, Sponsor: Washington University School of Medicine
N=20 --> 2 | Active, not recruiting --> Terminated; Lack of effect in initial subjects Active, not recruiting --> Completed | N=150 --> 101 | Trial completion date: Apr 2018 --> Jul 2017 | Trial primary completion date: Apr 2018 --> Jul 2017
- | Enrollment closed, Trial completion date, Trial primary completion date: Tracking Neurodegeneration in Early Wolfram Syndrome (clinicaltrials.gov) - May 1, 2018
P=N/A, N=150, Active, not recruiting, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed | N=150 --> 101 | Trial completion date: Apr 2018 --> Jul 2017 | Trial primary completion date: Apr 2018 --> Jul 2017 Recruiting --> Active, not recruiting | Trial completion date: Apr 2017 --> Apr 2018 | Trial primary completion date: Apr 2017 --> Apr 2018
- | Trial completion, Trial completion date, Trial primary completion date: Use of Copeptin in Diabetes Insipidus (clinicaltrials.gov) - Apr 17, 2018
P=N/A, N=156, Completed, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Active, not recruiting | Trial completion date: Apr 2017 --> Apr 2018 | Trial primary completion date: Apr 2017 --> Apr 2018 Recruiting --> Completed | Trial completion date: Dec 2018 --> Dec 2017 | Trial primary completion date: Dec 2018 --> Jun 2017
- | metformin / Generic mfg.
Enrollment closed, Trial primary completion date: Metformin and Congenital Nephrogenic Diabetes Insipidus (clinicaltrials.gov) - Jul 12, 2017
P1, N=20, Active, not recruiting, Sponsor: Emory University
Recruiting --> Completed | Trial completion date: Dec 2018 --> Dec 2017 | Trial primary completion date: Dec 2018 --> Jun 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Jun 2020
- | Trial completion, Enrollment change: Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome (clinicaltrials.gov) - Jul 11, 2017
P=N/A, N=60, Completed, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Jun 2020 Recruiting --> Completed | N=40 --> 60
- | Trial primary completion date: Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome (clinicaltrials.gov) - Mar 14, 2017
P=N/A, N=40, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Completed | N=40 --> 60 Trial primary completion date: Feb 2017 --> Jun 2017
- fesoterodine / Generic mfg., desmopressin / Generic mfg.
Enrollment change, Trial initiation date, Trial termination, Trial primary completion date: Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older (clinicaltrials.gov) - Nov 15, 2016
P2/3, N=4, Terminated, Sponsor: Mount Sinai Hospital, Canada
Trial primary completion date: Feb 2017 --> Jun 2017 N=132 --> 4 | Initiation date: Dec 2014 --> Jul 2015 | Not yet recruiting --> Terminated | Trial primary completion date: May 2016 --> Feb 2016; Poor recruitment
- Trial completion: COPA: Study of Copeptin as a Diagnostic Marker for Acute Pancreatitis (clinicaltrials.gov) - Oct 25, 2016
P=N/A, N=150, Completed, Sponsor: University Hospital, Basel, Switzerland
N=132 --> 4 | Initiation date: Dec 2014 --> Jul 2015 | Not yet recruiting --> Terminated | Trial primary completion date: May 2016 --> Feb 2016; Poor recruitment Active, not recruiting --> Completed
- Trial primary completion date: Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome (clinicaltrials.gov) - Apr 28, 2016
P=N/A, N=40, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Dec 2016
- metformin / Generic mfg.
Trial primary completion date: Metformin and Congenital Nephrogenic Diabetes Insipidus (clinicaltrials.gov) - Apr 21, 2016
P1, N=20, Recruiting, Sponsor: Emory University
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Jun 2016 --> Jun 2017
- Enrollment closed: COPA: Study of Copeptin as a Diagnostic Marker for Acute Pancreatitis (clinicaltrials.gov) - Dec 16, 2015
P=N/A, N=150, Active, not recruiting, Sponsor: University Hospital, Basel, Switzerland
Trial primary completion date: Jun 2016 --> Jun 2017 Recruiting --> Active, not recruiting
- New trial: REGAVP: Regulation of Arginine-vasopressin (AVP) (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=25, Completed, Sponsor: Yale University
- metformin / Generic mfg.
Enrollment open: Metformin and Congenital Nephrogenic Diabetes Insipidus (clinicaltrials.gov) - Oct 22, 2015
P1, N=20, Recruiting, Sponsor: Emory University
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- New trial: Effect of Statin Treatment on Urinary AQP2 (uAQP2/01) (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=37, Completed, Sponsor: University of Bari
- | tolvaptan / Generic mfg.
Trial completion: A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) (clinicaltrials.gov) - Jun 23, 2015
P1/2, N=30, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Not yet recruiting --> Recruiting Recruiting --> Completed
- Trial primary completion date: COPA: Study of Copeptin as a Diagnostic Marker for Acute Pancreatitis (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=130, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Completed Trial primary completion date: Mar 2015 --> Dec 2015
- metformin / Generic mfg.
New P1 trial: Metformin and Congenital Nephrogenic Diabetes Insipidus (clinicaltrials.gov) - Jun 2, 2015
P1, N=20, Not yet recruiting, Sponsor: Emory University
- New trial: Tracking Neurodegeneration in Early Wolfram Syndrome (clinicaltrials.gov) - May 27, 2015
P=N/A, N=150, Recruiting, Sponsor: Washington University School of Medicine
- Trial primary completion date: Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=40, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Trial primary completion date: Mar 2015 --> Dec 2015 Trial primary completion date: Mar 2015 --> Dec 2015
- Trial initiation date, Trial primary completion date: Use of Copeptin in Diabetes Insipidus (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=140, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Trial primary completion date: Mar 2015 --> Dec 2015 Initiation date: Jul 2013 --> Jan 2015 | Trial primary completion date: Jul 2015 --> Dec 2018
- Trial termination: Oxytocin and Arginine Vasopressin in Pain Relief (clinicaltrials.gov) - Mar 7, 2015
P=N/A, N=167, Terminated, Sponsor: National Institute of Mental Health (NIMH)
Initiation date: Jul 2013 --> Jan 2015 | Trial primary completion date: Jul 2015 --> Dec 2018 Recruiting --> Terminated
- tolvaptan / Generic mfg.
Trial primary completion date: A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) (clinicaltrials.gov) - Jan 8, 2015
P1/2, N=30, Recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting --> Terminated Trial primary completion date: Dec 2014 --> May 2015
- Trial completion, Trial primary completion date: Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study (clinicaltrials.gov) - Dec 17, 2014
P=N/A, N=50, Completed, Sponsor: University Hospital, Basel, Switzerland
Trial primary completion date: Dec 2014 --> May 2015 Recruiting --> Completed | Trial primary completion date: Jun 2013 --> Oct 2014
- Trial primary completion date: COPA: Study of Copeptin as a Diagnostic Marker for Acute Pancreatitis (clinicaltrials.gov) - Dec 12, 2014
P=N/A, N=130, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Completed | Trial primary completion date: Jun 2013 --> Oct 2014 Trial primary completion date: Sep 2013 --> Mar 2015
- | Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: Vasopressin in Traumatic Hemorrhagic Shock Study (clinicaltrials.gov) - Nov 5, 2014
P2/3, N=64, Completed, Sponsor: Volker Wenzel
Trial primary completion date: Sep 2013 --> Mar 2015 Not yet recruiting --> Completed | N=200 --> 64 | Initiation date: Jan 2009 --> Jul 2010 | Trial primary completion date: Jan 2011 --> Oct 2014
- tolvaptan / Generic mfg.
Trial primary completion date: A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) (clinicaltrials.gov) - Oct 28, 2014
P1/2, N=30, Recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Not yet recruiting --> Completed | N=200 --> 64 | Initiation date: Jan 2009 --> Jul 2010 | Trial primary completion date: Jan 2011 --> Oct 2014 Trial primary completion date: Sep 2014 --> Dec 2014
- || fesoterodine / Generic mfg., desmopressin / Generic mfg.
New P2/3 trial: Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older (clinicaltrials.gov) - Oct 15, 2014
P2/3, N=132, Not yet recruiting, Sponsor: Mount Sinai Hospital, Canada
- Trial primary completion date: Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome (clinicaltrials.gov) - May 18, 2014
P=N/A, N=40, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Trial primary completion date: Sep 2014 --> Dec 2014 Trial primary completion date: Mar 2014 --> Mar 2015
- Trial completion: Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis (clinicaltrials.gov) - May 18, 2014
P=N/A, N=125, Completed, Sponsor: University Hospital, Basel, Switzerland
Trial primary completion date: Mar 2014 --> Mar 2015 Recruiting --> Completed
- Trial completion: ESWP: Efficacy Study of Water Drinking on PKD Progression. (clinicaltrials.gov) - Dec 20, 2013
P=N/A, N=30, Completed, Sponsor: Kyorin University
Recruiting --> Completed Recruiting --> Completed
- | tolvaptan / Generic mfg.
New P1/2 trial: A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) (clinicaltrials.gov) - Dec 10, 2013
P1/2, N=30, Recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
- Enrollment open: Use of Copeptin in Diabetes Insipidus (clinicaltrials.gov) - Sep 11, 2013
P=N/A, N=140, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Completed Not yet recruiting --> Recruiting
- desmopressin / Generic mfg.
Trial completion, Surgery: Desmopressin in Cardiac Surgery (clinicaltrials.gov) - Jun 4, 2013
P4, N=0, Completed, Sponsor: Universit
Not yet recruiting --> Recruiting Recruiting --> Completed
- Trial completion: Electrolyte and Fluid Disturbances in Subarachnoid Hemorrhage and Traumatic Brain Injury (clinicaltrials.gov) - Apr 15, 2013
P=N/A, N=85, Completed, Sponsor: University Hospital Inselspital, Berne
Recruiting --> Completed Enrolling by invitation --> Completed
- Enrollment open: COPA: Study of Copeptin as a Diagnostic Marker for Acute Pancreatitis (clinicaltrials.gov) - Jan 23, 2013
P=N/A, N=130, Recruiting, Sponsor: University Hospital, Basel, Switzerland
Enrolling by invitation --> Completed Not yet recruiting --> Recruiting
- sildenafil / Generic mfg., indomethacin / Generic mfg., amiloride/hydrochlorothiazide / Generic mfg.
Enrollment change: Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus (clinicaltrials.gov) - Dec 18, 2012
P=N/A, N=4, Completed, Sponsor: University of Colorado, Denver
Not yet recruiting --> Recruiting N=40 --> 4
- sildenafil / Generic mfg., indomethacin / Generic mfg., amiloride/hydrochlorothiazide / Generic mfg.
Trial completion: Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus (clinicaltrials.gov) - Dec 18, 2012
P=N/A, N=4, Completed, Sponsor: University of Colorado, Denver
N=40 --> 4 Recruiting --> Completed
- || desmopressin / Generic mfg.
Trial completion: A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI). (clinicaltrials.gov) - Aug 9, 2012
P3, N=20, Completed, Sponsor: Ferring Pharmaceuticals
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Vasopressin Deficiency in Hemorrhagic Shock (clinicaltrials.gov) - Mar 6, 2012
P=N/A, N=81, Completed, Sponsor: The University of Texas Health Science Center at San Antonio
Active, not recruiting --> Completed N=50 --> 81
- Trial completion: Vasopressin Deficiency in Hemorrhagic Shock (clinicaltrials.gov) - Mar 6, 2012
P=N/A, N=81, Completed, Sponsor: The University of Texas Health Science Center at San Antonio
N=50 --> 81 Recruiting --> Completed
- Clinical: Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis (clinicaltrials.gov) - Nov 3, 2011
P=N/A, N=125, Recruiting, Sponsor: University Hospital, Basel, Switzerland